GLR Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2134831 COLUMBIA, MD

Position in LLY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$3,124,515

+$677,008 QoQ

Shares Held

2,605

-2.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

3.35%

of 13F equity value

Holder Rank

#2,089

of 4,605 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLR Partners, LLC holds $5,335,585 across 4 Drug Manufacturers - General names. LLY ranks #1 (58.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,605	$3,124,515
2	JNJ	Johnson & Johnson	5,342	$1,356,707
3	GILD	Gilead Sciences, Inc.	3,904	$493,231
4	NVO	Novo Nordisk A S	7,533	$361,132

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,124,515	2,605	-2.1%	Shares	Sole	2026-07-27
2026-03-31	$2,447,507	2,661	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.